Allegra Andrea Gaetano, Nicosia Luca, Rigo Michele, Bianchi Nicola, Borgese Riccardo Filippo, De Simone Antonio, Giaj-Levra Niccolò, Gurrera Davide, Naccarato Stefania, Pastorello Edoardo, Ricchetti Francesco, Sicignano Gianluisa, Ruggieri Ruggero, Alongi Filippo
Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Verona, Negrar, Italy.
University of Brescia, Brescia, Italy.
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338241297231. doi: 10.1177/15330338241297231.
MR-guided radiotherapy (MRgRT) is novel treatment modality in Radiation Oncology that could allow a higher precision and tolerability of Radiation Treatments. This modality is possible due to dedicated systems consisting of a MR scanner mounted on a conventional linac and software that permit daily online treatment plan adaptation. Prostate cancer (PC) is one of the most common malignancies in RO clinical practice and currently under investigation with this new technology. The focus of this review is to describe the current state of the art and clinical results of MRgRT in the treatment of PC. The available technology are briefly described, as well as the published literature and possible future applications.
磁共振引导放射治疗(MRgRT)是放射肿瘤学中的一种新型治疗方式,它可以提高放射治疗的精度和耐受性。这种治疗方式之所以可行,是因为有专门的系统,该系统由安装在传统直线加速器上的磁共振扫描仪和允许每日在线调整治疗计划的软件组成。前列腺癌(PC)是放射肿瘤学临床实践中最常见的恶性肿瘤之一,目前正在使用这项新技术进行研究。本综述的重点是描述MRgRT在前列腺癌治疗中的当前技术水平和临床结果。简要介绍了可用技术、已发表的文献以及可能的未来应用。